Raloxifene Impurity 25 | CAS 177744-96-6 - Request Quote
Raloxifene Impurity 25
| SZ CAT No: | SZ-R007043 |
| CAS No | 177744-96-6 |
| Mol.F. | C21H14O4S |
| Mol.Wt. | 362.4 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Raloxifene Impurity 25 is chemically (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-hydroxyphenyl)methanone. Raloxifene Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Raloxifene Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Raloxifene.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 177744-96-6
Purchase 177744-96-6
Order 177744-96-6
Enquire 177744-96-6
price of 177744-96-6
177744-96-6 Supplier
177744-96-6 Manufacturer
177744-96-6 Exporter
buy high quality Raloxifene Impurity 25
Purchase Raloxifene Impurity 25
Raloxifene Impurity 25 suppliers
Raloxifene Impurity 25 manufacturers
Raloxifene Impurity 25 price
Order Raloxifene Impurity 25
Enquire Raloxifene Impurity 25
Raloxifene Impurity 25 cost
Raloxifene Impurity 25 Supplier
Raloxifene Impurity 25 Distributor
Raloxifene Impurity 25 for Method Validation
Raloxifene Reference Standard
Raloxifene Impurity 25 for ANDA Filing
Raloxifene Impurity 25 for Forced Degradation Studies
Raloxifene Impurity 25 Identification Standards
Raloxifene Impurity 25 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.